The inflammasome: An integrated view

Immunological Reviews

Volumn 243, Issue 1, 2011, Pages 136-151

  Gross, Olaf ^a   Thomas, Christina J ^a   Guarda, Greta ^a   Tschopp, Jurg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Caspase 1; IL 1 ; Inflammasome; Negative feedback; NLRP3; Priming

Indexed keywords

ANTIINFLAMMATORY AGENT; APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; COLCHICINE; CRYOPYRIN; CYTOCHALASIN D; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INTERFERON; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LATRUNCULIN B; MYELOID DIFFERENTIATION FACTOR 88; POTASSIUM ION; PROTEIN AIM2; PROTEIN KINASE SYK; PROTEIN KINASE TYK2; PROTEIN NLRC4; PROTEIN NLRP1; PROTEIN PRECURSOR; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ACUTE PERITONITIS; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MACROPHAGE; CELL DAMAGE; CELL DEATH; CELL STRESS; CELL SURVIVAL; CELLULAR IMMUNITY; COMPARATIVE STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENTEROCOLITIS; ENZYME ACTIVATION; GOUT; HEMATOPOIETIC STEM CELL; HOST RESISTANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROMOLECULE; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NEGATIVE FEEDBACK; NEUTROPHIL; NONHUMAN; PERITONEUM EXUDATE; PERITONITIS; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; SRC HOMOLOGY DOMAIN;

ANIMALS; CARRIER PROTEINS; FEEDBACK, PHYSIOLOGICAL; HUMANS; IMMUNITY; INFLAMMASOMES; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION;

EID: 80052164574     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2011.01046.x     Document Type: Article

References (155)

1. Mariathasan S, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004;430:213-218.
2. Martinon F, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-241.
3. Kool M, et al. Cutting dege: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008;181:3755-3759.
4. Hornung V, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008;9:847-856.
5. Eisenbarth SC, et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008;453:1122-1126.
6. Ting JPY, Willingham SB, Bergstralh DT. NLRs at the intersection of cell death and immunity. Nat Rev Immunol 2008;8:372-379.
7. Gross O, et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009;459:433-436.
8. Joly S, et al. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 2009;183:3578-3581.
9. Hise AG, et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009;5:487-497.
10. Allen IC, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009;30:556-565.
11. Thomas PG, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009;30: 566-575.
12. Bauernfeind FG, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009;183:787-791.
13. Franchi L, Eigenbrod T, Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 2009;183:792-796.
14. O'Connor W Jr, et al. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. J Immunol 2003;171:6329-6333.
15. Guarda G, et al. Differential expression of NLRP3 among hematopoietic cells. J Immunol 2011;186:2529-2534.
16. Guarda G, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011;34:213-223.
17. Netea MG, et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009;113:2324-2335.
18. Li P, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995;80:401-411.
19. Lamkanfi M, et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 2010;185:4385-4392.
20. Sutterwala FS, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006;24:317-327.
21. Zheng H, et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 1995;3:9-19.
22. Fantuzzi G, et al. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 1996;157:291-296.
23. Joosten LA, et al. Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1alpha, IL-1beta or IL-1 receptor type I. APMIS 2010;118:1000-1007.
24. Shao W, et al. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem 2007;282:36321-36329.
25. Willingham SB, et al. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol 2009;183:2008-2015.
26. Sha Y, et al. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008;180:2531-2537.
27. Hoffman HM, et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301-305.
28. Anderson JP, et al. Initial description of the human NLRP3 promoter. Genes Immun 2008;9:721-726.
29. Chen CJ, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006;116:2262-2271.
30. Yazdi AS, et al. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci USA 2010;107:19449-19454.
31. Iyer SS, et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 2009;106:20388-20393.
32. Narayan S, et al. Octacalcium phosphate crystals induce inflammation in vivo through interleukin-1 but independent of the NLRP3 inflammasome in mice. Arthritis Rheum 2011;63:422-433.
33. Eigenbrod T, et al. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol 2008;181:8194-8198.
34. Fernandes-Alnemri T, et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 2007;14:1590-1604.
35. Netea MG, et al. IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog 2010;6:e1000661.
36. Guma M, et al. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum 2009;60:3642-3650.
37. Dalbeth N, So A. Hyperuricaemia and gout: state of the art and future perspectives. Ann Rheum Dis 2010;69:1738-1743.
38. Hacham M, et al. Different patterns of interleukin-1alpha and interleukin-1beta expression in organs of normal young and old mice. Eur Cytokine Netw 2002;13:55-65.
39. de Waal Malefyt R, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
40. Fiorentino DF, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
41. Berg DJ, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996;98:1010-1020.
42. Pils MC, et al. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur J Immunol 2010;40:443-448.
43. Takeda K, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49.
44. Chang EY, et al. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 2007;178:6705-6709.
45. Radwan M, et al. Tyrosine kinase 2 controls IL-1beta production at the translational level. J Immunol 2010;185:3544-3553.
46. Wang P, et al. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994;153:811-816.
47. Kaiser F, et al. TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells. J Exp Med 2009;206:1863-1871.
48. Glocker EO, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361:2033-2045.
49. Remmers EF, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010;42:698-702.
50. Botsios C, et al. Resistant Behcet disease responsive to anakinra. Ann Intern Med 2008;149:284-286.
51. Gul A. Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005;4:81-83.
52. Burckstummer T, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009;10:266-272.
53. Choubey D, Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett 2008;119:32-41.
54. Fernandes-Alnemri T, et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010;11:385-393.
55. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-426.
56. Mayor A, et al. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat Immunol 2007;8:497-503.
57. Poyet JL, et al. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 2001;276:28309-28313.
58. Cassel SL, et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 2008;105:9035-9040.
59. Cruz CM, et al. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 2007;282:2871-2879.
60. Dostert C, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008;320:674-677.
61. Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-832.
62. Petrilli V, et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007;14:1583-1589.
63. Shio MT, et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 2009;5:e1000559.
64. Halle A, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008;9:857-865.
65. Hornung V, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009;458:514-518.
66. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006;38:240-244.
67. Franchi L, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 2006;7:576-582.
68. Poeck H, et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 2010;11:63-69.
69. Medzhitov R. Approaching the asymptote: 20years later. Immunity 2009;30:766-775.
70. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
71. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007;8:405-413.
72. Cain K, et al. Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome. J Biol Chem 2001;276:41985-41990.
73. Brown GC, Borutaite V. Regulation of apoptosis by the redox state of cytochrome c. Biochim Biophys Acta 2008;1777:877-881.
74. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008;27:6434-6451.
75. Yuan XM, et al. Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci USA 2002;99:6286-6291.
76. Fink SL, Bergsbaken T, Cookson BT. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci USA 2008;105:4312-4317.
77. Arlehamn CS, et al. The role of potassium in inflammasome activation by bacteria. J Biol Chem 2010;285:10508-10518.
78. Muruve DA, et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008;452:103-107.
79. Franchi L, et al. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 2007;282:18810-18818.
80. Mariathasan S, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006;440:228-232.
81. Kanneganti TD, et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007;26:433-443.
82. Perregaux D, Gabel CA. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 1994;269:15195-15203.
83. Lamkanfi M, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 2009;187:61-70.
84. Link TM, et al. TRPV2 has a pivotal role in macrophage particle binding and phagocytosis. Nat Immunol 2010;11:232-239.
85. Flach TL, et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med 2011;17:479-487.
86. Ng G, et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008;29:807-818.
87. Schorn C, et al. Sodium overload and water influx activate the NALP3 inflammasome. J Biol Chem 2011;286:35-41.
88. Qu Y, et al. Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J Immunol 2011;186:6553-6561.
89. Karki P, et al. Intracellular K+ inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release. Cell Death Differ 2007;14:2068-2075.
90. Dostert C, et al. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS ONE 2009;4:e6510.
91. Duewell P, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464:1357-1361.
92. Shimada T, et al. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 2010;7:38-49.
93. Goodridge HS, et al. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature 2011;472:471-475.
94. Hackam DJ, et al. Rho is required for the initiation of calcium signaling and phagocytosis by Fcgamma receptors in macrophages. J Exp Med 1997;186:955-966.
95. Jongstra-Bilen J, Harrison R, Grinstein S. Fcgamma-receptors induce Mac-1 (CD11b/CD18) mobilization and accumulation in the phagocytic cup for optimal phagocytosis. J Biol Chem 2003;278: 45720-45729.
96. Underhill DM, et al. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 2005;106:2543-2550.
97. Steinberg BE, Grinstein S. Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants. J Clin Invest 2008;118:2002-2011.
98. Hornung V, Latz E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol 2010;40:620-623.
99. Bauernfeind F, et al. Inflammasomes: current understanding and open questions. Cell Mol Life Sci 2011;68:765-783.
100. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313.
101. Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol 2010;40:616-619.
102. Pollock JD, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995;9:202-209.
103. van de Veerdonk FL, et al. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci USA 2010;107:3030-3033.
104. Zhou R, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221-225.
105. Brookes PS, et al. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004;287:C817-C833.
106. West AP, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011;472:476-480.
107. Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 2008;409:19-26.
108. Nakahira K, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12:222-230.
109. Zhou L, et al. A reaction-diffusion model of ROS-induced ROS release in a mitochondrial network. PLoS Comput Biol 2010;6:e1000657.
110. Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 2005;8:3-5.
111. Saitoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008;456:264-268.
112. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Imunol 2008;8:458-466.
113. Tschopp J. Mitochondria: sovereign of inflammation? Eur J Immunol 2011;41:1196-1202.
114. Zhou R, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010;11:136-140.
115. Masters SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 2010;11:897-904.
116. Sato T, et al. Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol 2004;173:285-296.
117. Kim BM, Schultz LW, Raines RT. Variants of ribonuclease inhibitor that resist oxidation. Protein Sci 1999;8:430-434.
118. Avshalumov MV, Rice ME. Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc Natl Acad Sci USA 2003;100:11729-11734.
119. Ichinari K, et al. Direct activation of the ATP-sensitive potassium channel by oxygen free radicals in guinea-pig ventricular cells: its potentiation by MgADP. J Mol Cell Cardiol 1996;28:1867-1877.
120. Sesti F, Liu S, Cai SQ. Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration? Trends Cell Biol 2010;20:45-51.
121. Fay AJ, et al. SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. Proc Natl Acad Sci USA 2006;103:17548-17553.
122. Ghosh M, et al. Lysosomal membrane permeabilization causes oxidative stress and ferritin induction in macrophages. FEBS Lett 2011;585:623-629.
123. Boya P, et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003;197:1323-1334.
124. Blomgran R, Zheng L, Stendahl O. Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J Leukoc Biol 2007;81: 1213-1223.
125. Brough D, Rothwell NJ. Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J Cell Sci 2007;120:772-781.
126. Hersh D, et al. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA 1999;96:2396-2401.
127. Brennan MA, Cookson BT. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol 2000;38:31-40.
128. Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol 2001;9:113-114.
129. Fernandes-Alnemri T, et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009;458:509-513.
130. Li H, Ambade A, Re F. Cutting edge: necrosis activates the NLRP3 inflammasome. J Immunol 2009;183:1528-1532.
131. Bruey JM, et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007;129:45-56.
132. Greten FR, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007;130:918-931.
133. Guarda G, et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009;460:269-273.
134. Quezada SA, et al. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004;22:307-328.
135. Beamer CA., et al. Innate immune processes are sufficient for driving silicosis in mice. J Leukoc Biol 2010;88:547-557.
136. Kim KD, et al. Adaptive immune cells temper initial innate responses. Nat Med 2007;13:1248-1252.
137. Shanker A. Adaptive control of innate immunity. Immunol Lett 2010;131:107-112.
138. Kadowaki N, et al. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 2000;192:219-226.
139. Theofilopoulos AN, et al. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005;23:307-336.
140. Schonthaler HB, Guinea-Viniegra J, Wagner EF. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis 2011;70(Suppl):i109-i112.
141. Wullaert A, Bonnet MC, Pasparakis M. NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res 2011;21:146-158.
142. Kuida K, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995;267:2000-2003.
143. Keller M, et al. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008;132:818-831.
144. Nickel W, Seedorf M. Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu Rev Cell Dev Biol 2008;24:287-308.
145. Andrei C, et al. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 1999;10:1463-1475.
146. Andrei C, et al. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc Natl Acad Sci USA 2004;101:9745-9750.
147. MacKenzie A, et al. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001;15:825-835.
148. Qu Y, et al. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 2007;179:1913-1925.
149. Ebert AD, et al. Tec-kinase-mediated phosphorylation of fibroblast growth factor 2 is essential for unconventional secretion. Traffic 2010;11:813-826.
150. Schafer T, et al. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem 2004;279:6244-6251.
151. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011;11:213-220.
152. Lamkanfi M, et al. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol Cell Proteomics 2008;7:2350-2363.
153. Agard NJ, Maltby D, Wells JA. Inflammatory stimuli regulate caspase substrate profiles. Mol Cell Proteomics 2010;9:880-893.
154. Akhter A, et al. Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. PLoS Pathog 2009;5:e1000361.
155. Gurcel L, et al. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006;126:1135-1145.